According to Glenmark Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is ยฃ0.08499. In 2022 the company made an earnings per share (EPS) of ยฃ0.30 a decrease over its 2021 EPS that were of ยฃ0.38.